Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

NCT00006390 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: alemtuzumab
BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]